BP003058: Biotinylated Recombinant SARS Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003055: Biotinylated Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S1-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.Custom Ilama and alpaca monoclonal antibody development (VHH, sdAb or nanobody) by Ilama or alpaca immunization and phage display screening.
Production of camel, Ilama or alpaca VHH in E.coli or VHH-Fc in HEK 293 cells.
Fast turnaround: 4-6 months once the antigen is available.C100P: Casirivimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Human IgG1 Kappa Monoclonal Antibody.
Specificity/Sensitivity: The casirivimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by casirivimab.BP003062: Recombinant Human ACE2-Fc-Avi Protein (rhACE2-Fc)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S RBD with the His Tag at 1 ug/ml (100 ul/well). Dose response curve for rhACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003059: Recombinant SARS Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003053: Recombinant SARS-CoV-2 Nucleocapsid Protein-His-Avi (NP Protein, N Protein)
Source: E.coli.
Purity: > 95% by PAGE under reduced condition.BP003052: Recombinant SARS-CoV-2 Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003057: Recombinant SARS-CoV-2 Spike S-Fc Protein
Source: HEK 293 cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003054: Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized recombinant SARS-CoV-2 Spike S1-His-Avi protein at 0.5 ug/ml (100 ul/well). Dose response curve for the biotinylated recombinant human ACE2-His fusion protein with the EC50 of 0.2 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.